Laryngeal preservation in head and neck cancer: multidisciplinary approach

Lancet Oncology

Volumn 7, Issue 9, 2006, Pages 747-755

  Lefebvre, Jean Louis ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; BODY WEIGHT DISORDER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARBON DIOXIDE LASER; CLINICAL RESEARCH; CLINICAL TRIAL; ENDOSCOPIC SURGERY; ESOPHAGUS STENOSIS; HEAD AND NECK CANCER; HUMAN; IMAGING SYSTEM; LARYNGECTOMY; LARYNX CANCER; LASER SURGERY; MEDICAL DECISION MAKING; MUCOSA INFLAMMATION; PATIENT SELECTION; PHARYNX CANCER; PHARYNX RECONSTRUCTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNX;

EID: 33747840348     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70860-9     Document Type: Review

References (81)

1. Weinstein G. Surgical approach to organ preservation in the treatment of cancer of the larynx. Oncology (Williston Park) 15 (2001) 785-796
2. Teknos T., Hogikyan N., and Wolf G. Conservation laryngeal surgery for malignant tumors of the larynx and pyriform sinus. Hematol Oncol Clin North Am 15 (2001) 261-276
3. Lefebvre J., Coche-Dequeant B., Degardin M., et al. Treatment of laryngeal cancer: the permanent challenge. Expert Rev Anticancer Ther 4 (2004) 913-920
4. Chevalier D., Watelet J., Darras J., and Piquet J. Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma. Head Neck 19 (1997) 1-5
5. Laccourreye O., Ishoo E., de Mones E., et al. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus, part I: technique, complications, and long-term functional outcome. Ann Otol Rhinol Laryngol 114 (2005) 25-34
6. Laccourreye H., Laccourreye O., Weinstein G., et al. Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 100 (1990) 735-741
7. Laccourreye H., Laccourreye O., Weinstein G., et al. Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma. Ann Otol Rhinol Laryngol 99 (1990) 421-426
8. Chevalier D., Laccourreye O., Brasnu D., et al. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 106 (1997) 364-369
9. Lima R., Freitas E., Kligerman J., et al. Near-total laryngectomy for treatment of advanced laryngeal cancer. Am J Surg 174 (1997) 490-491
10. Laccourreye O., Brasnu D., Biacabe B., et al. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck 20 (1998) 595-599
11. Makeieff M., Venegoni D., Mercante G., et al. Supracricoid partial laryngectomies after failure of radiation therapy. Laryngoscope 115 (2005) 353-357
12. Weinstein G., El-Sawy M., Ruiz C., et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope 111 (2001) 191-199
13. Iro H., Waldfahrer F., Altendorf-Hofmann A., Weidenbecher M., Sauer R., and Steiner W. Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 124 (1998) 1245-1250
14. Motta G., Esposito E., Motta S., et al. CO(2) laser surgery in the treatment of glottic cancer. Head Neck 27 (2005) 566-573
15. Vilaseca-Gonzalez I., Bernal-Sprekelsen M., Blanch-Alejandro J., and Moragas-Lluis M. Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck 25 (2003) 382-388
16. Steiner W., Ambrosch P., Hess C., and Kron M. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 124 (2001) 58-67
17. Rudert H., and Hoft S. Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol 260 (2003) 198-206
18. Mendenhall W. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Radiat Oncol 8 (1998) 262-269
19. Jorgensen K., Godballe C., Hansen O., and Bastholt L. Cancer of the larynx: treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 41 (2002) 69-76
20. Keum K., Kim G., Suh C., et al. Role of definitive radiation therapy for larynx preservation in patients with advanced laryngeal cancer. J Otolaryngol 28 (1999) 245-251
21. Wang C. Carcinoma of the larynx. In: Wang C. (Ed). Radiation therapy for head and neck neoplasms. 3rd edn. (1997), Wiley-Liss, New York 221-256
22. Niibe Y., Karasawa K., Mitsuhashi T., and Tanaka Y. Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survival. Jpn J Clin Oncol 33 (2003) 450-455
23. Overgaard J., Hansen H., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
24. Fu K., Pajak T., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
25. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
26. Bourhis J., Etessami A., Wilbault P., et al. Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations. Curr Opin Oncol 16 (2004) 215-219
27. Decker D, Drelichman A, Jacobs J, et al. Adjuvant chemotherapy with high dose bolus cis-diamminodichloroplatinum II (CDD) and 120 hour infusion 5-fluorouracil (5-FU) in stage III and IV squamous cell carcinoma of the head and neck. ASCO annual meeting 1982, Saint Louis: abstr C-757.
28. Decker D., Drelichman A., Jacobs J., et al. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51 (1983) 1353-1355
29. Ensley J, Jacobs J, Weaver A, et al. Initial cis-platinum combination predicting response to radiotherapy in patients with advanced epidermoid cancers of the head and neck. ASCO annual meeting 1982, Saint Louis: abstr C-767.
30. Ensley J., Jacobs J., Weaver A., et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54 (1984) 811-814
31. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
32. Richard J., Sancho-Garnier H., Pessey J., et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34 (1998) 224-228
33. Lefebvre J., Chevalier D., Luboinski B., et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88 (1996) 890-899
34. Pignon J., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
35. Beauvillain C., Mahe M., Bourdin S., et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 107 (1997) 648-653
36. Price L., Shaw H., and Hill B. Larynx preservation after initial non-cisplatin containing combination chemotherapy plus radiotherapy, as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis after 12 years follow-up. J Laryngol Otol 107 (1993) 211-216
37. Leon X., Lopez-Pousa A., de Vega M., et al. Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol 262 (2005) 93-98
38. Eisbruch A., Thornton A., Urba S., et al. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. J Clin Oncol 14 (1996) 2322-2330
39. Thakar A., Bahadur S., Tandon D., et al. Laryngeal preservation by treatment with induction chemotherapy and radiotherapy protocol for stage III & IV carcinoma larynx: results of a pilot study. J Laryngol Otol 113 (1999) 433-438
40. Nikolaou A., Fountzilas G., Kosmidis P., et al. Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment. J Laryngol Otol 105 (1991) 930-933
41. Zelefsky M., Kraus D., Pfister D., et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 18 (1996) 405-411
42. Leon X., Quer M., Orus C., et al. Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced pyriform sinus carcinoma. Eur Arch Otorhinolaryngol 259 (2002) 32-36
43. Karp D., Vaughan C., Carter R., et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer: a long-term follow-up report. Am J Clin Oncol 14 (1991) 273-279
44. Clayman G., Weber R., Guillamondegui O., et al. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg 121 (1995) 219-223
45. Pfreundner L., Hoppe F., Willner J., et al. Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas: a possibility for organ preservation. Radiother Oncol 68 (2003) 163-170
46. Demard F., Chauvel P., Schneider M., et al. Induction chemotherapy for larynx preservation in laryngeal and hypopharyngeal cancers. In: Johnson J., and Didolkar M. (Eds). Head and neck cancer (1993), Elsevier, Amsterdam 3-10
47. Franchin G., Vaccher E., Gobitti C., et al. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma. Oral Oncol 41 (2005) 526-533
48. Spaulding M., Fischer S., and Wolf G. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12 (1994) 1592-1599
49. Bradford C., Zhu S., Wolf G., et al. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol Head Neck Surg 113 (1995) 408-412
50. Bradford C., Wolf G., Carey T., et al. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma. Otolaryngol Head Neck Surg 121 (1999) 534-538
51. Trask D., Wolf G., Bradford C., et al. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 112 (2002) 638-644
52. Teknos T., Cox C., Barrios M., et al. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope 112 (2002) 844-851
53. Osman I., Sherman E., Singh B., et al. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol 20 (2002) 2980-2987
54. Pivot X., Magne N., Guardiola E., et al. Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol 41 (2005) 320-327
55. Laccourreye O., Veivers D., Hans S., et al. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders. Cancer 92 (2001) 1504-1511
56. Bourhis J., Armand C., and Pignon J. Update of the MACH-NC (meta-analysis of chemotherapy in head and neck cancer) database focused on concomitant chemoradiotherapy. Proc Am Soc Clin Oncol 22 (2004) abstr 5505
57. Forastiere A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
58. Weber R., Berkey B., Forastiere A., et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 129 (2003) 44-49
59. Forastiere A., Maor M., Weber R., et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx-induction cisplatin/5FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. Proc Am Soc Clin Oncol 24 (2006) abstr 5517
60. de la Vega F., Garcia R., Dominguez D., et al. Hyperfractionated radiotherapy and concomitant cisplatin for locally advanced laryngeal and hypopharyngeal carcinomas: final results of a single institutional program. Am J Clin Oncol 26 (2003) 550-557
61. Hanna E., Alexiou M., Morgan J., et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 130 (2004) 861-867
62. Robbins K., Fontanesi J., Wong F., et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 122 (1996) 853-857
63. List M., Stracks J., Colangelo L., et al. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?. J Clin Oncol 18 (2000) 877-884
64. Terrell J., Fisher S., and Wolf G. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 964-971
65. Hanna E., Sherman A., Cash D., et al. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130 (2004) 875-879
66. Carrara-de Angelis E., Feher O., Barros A., et al. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 129 (2003) 733-738
67. Kotz T., Costello R., Li Y., and Posner M. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26 (2004) 365-372
68. Liberman P., Schultz C., Gomez M., et al. Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 130 (2004) 1265-1268
69. Fung K., Lyden T., Lee J., et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1395-1399
70. Leon X., Quer M., Orus C., et al. How much does it cost to preserve a larynx? An economic study. Eur Arch Otorhinolaryngol 257 (2000) 72-76
71. Davis G., Schwartz S., Veenstra D., and Yueh B. Cost comparison of surgery vs organ preservation for laryngeal cancer. Arch Otolaryngol Head Neck Surg 131 (2005) 21-26
72. Vermorken J., Remenar E., Van Herpen C., et al. Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for non-resectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971). Proc Am Soc Clin Oncol 22 (2004) abstr 5508
73. Calais G., Pointreau Y., Alfonsi M., et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer: preliminary results of GORTEC 2000-01. Proc Am Soc Clin Oncol 25 (2004) abstr 5506
74. Machtay M., Rosenthal D., Hershock D., et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 20 (2002) 3964-3971
75. Vokes E., Stenson K., Rosen F., et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21 (2003) 320-326
76. Guadagnolo B., Haddad R., Posner M., et al. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol 28 (2005) 371-378
77. Rivera F., Vega-Villegas M., Lopez-Brea M., et al. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx. Laryngoscope 114 (2004) 1163-1169
78. Altundag O., Gullu I., Altundag K., et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 27 (2005) 15-21
79. Bonner J., Giralt J., Harari P., et al. Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of the head and neck: a phase III study of high dose radiation therapy with or without cetuximab. Proc Am Soc Clin Oncol 22 (2004) abstr 5507
80. Bonner J., Harari P., Giralt J., et al. Improved preservation of the larynx with the addition of cetuximab to radiation for cancers of the larynx and hypopharynx. Proc Am Soc Clin Oncol 23 (2005) abstr 5533
81. Harari P., Chinnaiyan P., Durland W., et al. Surgical wound healing in advanced head and neck cancer patients undergoing neck dissection following high dose radiation ± cetuximab. Int J Radiat Oncol Biol Phys 57 suppl 1 (2003) S245-S246